IRME Stock — International Display Advertising Inc

International Display Advertising Inc (IRME)

Updated October 9, 2026.

IRME is a Stock. Its deepest 1-year drawdown was 98.0%.

IR-Med Inc. is an Israeli medical device company developing non-invasive optical monitoring devices for early detection of pressure injuries, diabetic foot ulcers, and middle ear infections in children. The company does not currently distribute to shareholders. This security may appeal to investors seeking exposure to medical device innovation without reliance on dividend income.

IRME performance

Returns are updating. IRME's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 98.0%.

IRME key facts

Asset type

Stock

Asset class

Equity

Inception date

01/07/1999

Distribution frequency

None

Last close

$0.0021 (stale; as of 2026-10-09)

Market cap

$231,126

Average volume

0.0

Payment date

02/26/2020

Beta

0.572

Payout ratio

0.0%

EPS

$-0.04

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

IRME risks and drawbacks

The deepest 1-year drawdown on record here is 98.0%.

Who may consider IRME — and who may not

It is a weaker fit for investors who need monthly cash flow (IRME does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on IRME

• All tickers starting with I

Tagged: International.

Frequently asked questions